Calliditas Therapeutics AB (publ) (CALT)

NASDAQ: CALT · IEX Real-Time Price · USD

38.79

+0.17 (0.44%)

At close: Jul 19, 2024, 12:00 AM

39.01

+0.22 (0.57%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

CALT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,041	767	502	618	778
Market Cap Growth	60.46%	52.65%	-18.74%	-20.55%	-
Enterprise Value	1,040	766	452	536	657
PE Ratio	-	-16.58	-12.67	-11.12	-14.72
PS Ratio	8.69	6.41	6.51	24.26	7301.43
PB Ratio	33.16	23.09	6.82	5.52	5.27
P/FCF Ratio	-17.28	-17.28	-16.65	-11.89	-20.64
P/OCF Ratio	-17.79	-17.79	-16.78	-12.06	-20.64
EV/Sales Ratio	8.69	6.40	5.86	21.03	6162.50
EV/EBITDA Ratio	-22.54	-22.54	-12.66	-9.74	-14.32
EV/EBIT Ratio	-22.54	-22.54	-12.66	-9.74	-14.32
EV/FCF Ratio	-17.26	-17.26	-14.99	-10.30	-17.42
Debt / Equity Ratio	2.89	2.89	0.95	0.21	0.00
Debt / EBITDA Ratio	-2.82	-2.82	-1.96	-0.43	0.00
Debt / FCF Ratio	-2.16	-2.16	-2.32	-0.46	0.00
Quick Ratio	2.84	2.84	4.08	7.05	9.43
Current Ratio	3.13	3.13	4.34	7.48	9.82
Asset Turnover	0.63	0.63	0.47	0.16	0.00
Interest Coverage	-3.00	-3.00	-9.87	-53.48	-6.60
Return on Equity (ROE)	-84.70%	-84.70%	-46.50%	-45.10%	-36.60%
Return on Assets (ROA)	-24.50%	-24.50%	-24.20%	-34.20%	-33.50%
Return on Capital (ROIC)	-28.67%	-28.67%	-28.22%	-42.94%	-31.35%
Earnings Yield	-4.44%	-6.03%	-7.89%	-8.99%	-6.79%
FCF Yield	-4.03%	-5.79%	-6.01%	-8.41%	-4.84%
Buyback Yield / Dilution	-19.30%	-0.80%	-18.35%	-7.88%	-
Total Shareholder Return	-19.30%	-0.80%	-18.35%	-7.88%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).